eurofunctional Physical Therapy in Parkinson's disease: a feasibility trial
- Conditions
- ervous system diseases, Pathological conditions, signs and symptoms, Parkinson's disease.
- Registration Number
- RBR-8n94qg
- Lead Sponsor
- niversidade do Estado de Santa Catarina
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Individuals diagnosed with Parkinson's disease confirmed by the neurologist according to London Brain Bank criteria (Hughes et al., 1992); 50-90 years, mild to moderate staging of disease (stages 1 to 3 according to the Hoehn and Yahr Scale); stable medication (on the same medication / dose for at least 4 weeks); cognitive level related to scholarity level (in Mini Mental State Exam).
Patients presenting other neurological disorders associated; presenting orthopedic pathologies and / or joint limitations that affect the musculoskeletal system and make it difficult and / or difficult to perform the training; individuals who can not perform walking independently.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expected outcome: Protocol viability. Variables: Execution safety (measured in percentage through the occurrence of serious imbalances that compromise the safety of the participants during the intervention, being considered as a limit a percentage of 20% of occurrences), adherence to the treatment (measured as percentage by attendance frequency Of the participants to the treatment sessions, being considered as a minimum percentage of 80% for each participant).<br>For purposes of sample calculation, the mean and standard deviation of the freezing gait score will be used as the primary outcome, assessed by the freezing of gait questionnaire (which contains 6 questions regarding the severity and frequency of the freezing).
- Secondary Outcome Measures
Name Time Method Effects of gait protocol on: gait velocity (evaluated through the 10-meter walk test, widely used and recommended for gait speed assessment in Parkinson's disease), functional mobility in single task and double task, through the test Timed Up and Go test in single and double task.To test the effect caused by the intervention will be used statistical tests according to the distribution of the data. The level of significance of 5% (p <0.05) will be adopted in all tests.